2023-09-282024-09-302024-09-30false15170920DOCTOR ADS LTD2024-11-1462020iso4217:GBPxbrli:pure151709202023-09-28151709202024-09-30151709202023-09-282024-09-30151709202023-09-27151709202023-09-27151709202023-09-272023-09-2715170920bus:SmallEntities2023-09-282024-09-3015170920bus:AuditExempt-NoAccountantsReport2023-09-282024-09-3015170920bus:AbridgedAccounts2023-09-282024-09-3015170920bus:PrivateLimitedCompanyLtd2023-09-282024-09-3015170920core:WithinOneYear2024-09-3015170920core:AfterOneYear2024-09-3015170920core:WithinOneYear2023-09-2715170920core:AfterOneYear2023-09-2715170920core:ShareCapital2024-09-3015170920core:SharePremium2024-09-3015170920core:RevaluationReserve2024-09-3015170920core:OtherReservesSubtotal2024-09-3015170920core:RetainedEarningsAccumulatedLosses2024-09-3015170920core:ShareCapital2023-09-2715170920core:SharePremium2023-09-2715170920core:RevaluationReserve2023-09-2715170920core:OtherReservesSubtotal2023-09-2715170920core:RetainedEarningsAccumulatedLosses2023-09-2715170920core:LandBuildings2024-09-3015170920core:PlantMachinery2024-09-3015170920core:Vehicles2024-09-3015170920core:FurnitureFittings2024-09-3015170920core:OfficeEquipment2024-09-3015170920core:NetGoodwill2024-09-3015170920core:IntangibleAssetsOtherThanGoodwill2024-09-3015170920core:ListedExchangeTraded2024-09-3015170920core:UnlistedNon-exchangeTraded2024-09-3015170920core:LandBuildings2023-09-2715170920core:PlantMachinery2023-09-2715170920core:Vehicles2023-09-2715170920core:FurnitureFittings2023-09-2715170920core:OfficeEquipment2023-09-2715170920core:NetGoodwill2023-09-2715170920core:IntangibleAssetsOtherThanGoodwill2023-09-2715170920core:ListedExchangeTraded2023-09-2715170920core:UnlistedNon-exchangeTraded2023-09-2715170920core:LandBuildings2023-09-282024-09-3015170920core:PlantMachinery2023-09-282024-09-3015170920core:Vehicles2023-09-282024-09-3015170920core:FurnitureFittings2023-09-282024-09-3015170920core:OfficeEquipment2023-09-282024-09-3015170920core:NetGoodwill2023-09-282024-09-3015170920core:IntangibleAssetsOtherThanGoodwill2023-09-282024-09-3015170920core:ListedExchangeTraded2023-09-282024-09-3015170920core:UnlistedNon-exchangeTraded2023-09-282024-09-3015170920core:MoreThanFiveYears2023-09-282024-09-3015170920core:Non-currentFinancialInstruments2024-09-3015170920core:Non-currentFinancialInstruments2023-09-2715170920dpl:CostSales2023-09-282024-09-3015170920dpl:DistributionCosts2023-09-282024-09-3015170920core:LandBuildings2023-09-282024-09-3015170920core:PlantMachinery2023-09-282024-09-3015170920core:Vehicles2023-09-282024-09-3015170920core:FurnitureFittings2023-09-282024-09-3015170920core:OfficeEquipment2023-09-282024-09-3015170920dpl:AdministrativeExpenses2023-09-282024-09-3015170920core:NetGoodwill2023-09-282024-09-3015170920core:IntangibleAssetsOtherThanGoodwill2023-09-282024-09-3015170920dpl:GroupUndertakings2023-09-282024-09-3015170920dpl:ParticipatingInterests2023-09-282024-09-3015170920dpl:GroupUndertakingscore:ListedExchangeTraded2023-09-282024-09-3015170920core:ListedExchangeTraded2023-09-282024-09-3015170920dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-09-282024-09-3015170920core:UnlistedNon-exchangeTraded2023-09-282024-09-3015170920dpl:CostSales2023-09-272023-09-2715170920dpl:DistributionCosts2023-09-272023-09-2715170920core:LandBuildings2023-09-272023-09-2715170920core:PlantMachinery2023-09-272023-09-2715170920core:Vehicles2023-09-272023-09-2715170920core:FurnitureFittings2023-09-272023-09-2715170920core:OfficeEquipment2023-09-272023-09-2715170920dpl:AdministrativeExpenses2023-09-272023-09-2715170920core:NetGoodwill2023-09-272023-09-2715170920core:IntangibleAssetsOtherThanGoodwill2023-09-272023-09-2715170920dpl:GroupUndertakings2023-09-272023-09-2715170920dpl:ParticipatingInterests2023-09-272023-09-2715170920dpl:GroupUndertakingscore:ListedExchangeTraded2023-09-272023-09-2715170920core:ListedExchangeTraded2023-09-272023-09-2715170920dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-09-272023-09-2715170920core:UnlistedNon-exchangeTraded2023-09-272023-09-2715170920core:NetGoodwill2024-09-3015170920core:IntangibleAssetsOtherThanGoodwill2024-09-3015170920core:LandBuildings2024-09-3015170920core:PlantMachinery2024-09-3015170920core:Vehicles2024-09-3015170920core:FurnitureFittings2024-09-3015170920core:OfficeEquipment2024-09-3015170920core:AfterOneYear2024-09-3015170920core:WithinOneYear2024-09-3015170920core:ListedExchangeTraded2024-09-3015170920core:UnlistedNon-exchangeTraded2024-09-3015170920core:ShareCapital2024-09-3015170920core:SharePremium2024-09-3015170920core:RevaluationReserve2024-09-3015170920core:OtherReservesSubtotal2024-09-3015170920core:RetainedEarningsAccumulatedLosses2024-09-3015170920core:NetGoodwill2023-09-2715170920core:IntangibleAssetsOtherThanGoodwill2023-09-2715170920core:LandBuildings2023-09-2715170920core:PlantMachinery2023-09-2715170920core:Vehicles2023-09-2715170920core:FurnitureFittings2023-09-2715170920core:OfficeEquipment2023-09-2715170920core:AfterOneYear2023-09-2715170920core:WithinOneYear2023-09-2715170920core:ListedExchangeTraded2023-09-2715170920core:UnlistedNon-exchangeTraded2023-09-2715170920core:ShareCapital2023-09-2715170920core:SharePremium2023-09-2715170920core:RevaluationReserve2023-09-2715170920core:OtherReservesSubtotal2023-09-2715170920core:RetainedEarningsAccumulatedLosses2023-09-2715170920core:NetGoodwill2023-09-2715170920core:IntangibleAssetsOtherThanGoodwill2023-09-2715170920core:LandBuildings2023-09-2715170920core:PlantMachinery2023-09-2715170920core:Vehicles2023-09-2715170920core:FurnitureFittings2023-09-2715170920core:OfficeEquipment2023-09-2715170920core:AfterOneYear2023-09-2715170920core:WithinOneYear2023-09-2715170920core:ListedExchangeTraded2023-09-2715170920core:UnlistedNon-exchangeTraded2023-09-2715170920core:ShareCapital2023-09-2715170920core:SharePremium2023-09-2715170920core:RevaluationReserve2023-09-2715170920core:OtherReservesSubtotal2023-09-2715170920core:RetainedEarningsAccumulatedLosses2023-09-2715170920core:AfterOneYear2023-09-282024-09-3015170920core:WithinOneYear2023-09-282024-09-3015170920core:Non-currentFinancialInstrumentscore:CostValuation2023-09-282024-09-3015170920core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-09-282024-09-3015170920core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-09-282024-09-3015170920core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-09-282024-09-3015170920core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-09-282024-09-3015170920core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-09-282024-09-3015170920core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-09-282024-09-3015170920core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-09-282024-09-3015170920core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-09-282024-09-3015170920core:Non-currentFinancialInstrumentscore:CostValuation2024-09-3015170920core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-09-3015170920core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-09-3015170920core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-09-3015170920core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-09-3015170920core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-09-3015170920core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-09-3015170920core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-09-3015170920core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-09-3015170920core:Non-currentFinancialInstrumentscore:CostValuation2023-09-2715170920core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-09-2715170920core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-09-2715170920core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-09-2715170920core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-09-2715170920core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-09-2715170920core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-09-2715170920core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-09-2715170920core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-09-2715170920bus:Director12023-09-282024-09-30

DOCTOR ADS LTD

Registered Number
15170920
(England and Wales)

Unaudited Financial Statements for the Period ended
30 September 2024

DOCTOR ADS LTD
Company Information
for the period from 28 September 2023 to 30 September 2024

Director

IVITSKYI, Igor, Dr

Registered Address

128 City Road
London
EC1V 2NX

Registered Number

15170920 (England and Wales)
DOCTOR ADS LTD
Balance Sheet as at
30 September 2024

Notes

2024

£

£

Fixed assets
Tangible assets31,924
1,924
Current assets
Debtors600
Cash at bank and on hand1,862
2,462
Creditors amounts falling due within one year(4,671)
Net current assets (liabilities)(2,209)
Total assets less current liabilities(285)
Net assets(285)
Capital and reserves
Called up share capital1
Profit and loss account(286)
Shareholders' funds(285)
The financial statements were approved and authorised for issue by the Director on 14 November 2024, and are signed on its behalf by:
IVITSKYI, Igor, Dr
Director
Registered Company No. 15170920
DOCTOR ADS LTD
Notes to the Financial Statements
for the period ended 30 September 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
2.Average number of employees

2024
Average number of employees during the year3
3.Tangible fixed assets

Total

£
Cost or valuation
Additions3,299
At 30 September 243,299
Depreciation and impairment
Charge for year1,375
At 30 September 241,375
Net book value
At 30 September 241,924
At 27 September 23-